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Toxicological Effects of Chlorite
in the Mouse
by Gary S. Moore* and Edward J. Calabrese*
When exposed to a maximum level of 100 ppm chlorine dioxide in theirdrinking water, neither
A/J or C57L/J mice exhibited any hematologic changes. Chlorite exposure under similar
conditions produced increases for red blood cells in osmotic fragility, mean corpuscular volume,
and glucose-6-phosphate dehydrogenase activity for both strains. Chlorite exposure ofpregnant
A/J mice resulted in a significant decrease in the weight ofpups at weaning and a lower average
birth to weaning growth rate. Mice exposed to as much as 100 ppm sodium chlorite (NaCI02) in
their drinking water for up to 120 days failed to demonstrate any histopathological changes in
kidney structure.
Introduction
The primary method of water disinfection in the
United States employs chlorine. Studies, however,
have shown that chlorine interacts with organics in
the water to form trihalomethanes (1,2). One ofthe
trihalomethanes is chloroform, which has been
found to be carcinogenic in rats (3). It has been
postulated that chlorinated water supplies may
increase the risk of cancer to humans (4-7); such
compounds are formed to a lesser extent in water
disinfected with chlorine dioxide (8). While toxico-
logical studies have revealed limited physiologic
effects from chlorine dioxide, concern has now been
directed towards the end products of such disinfec-
tion which include chlorate and chlorite (7,8). Chlo-
rites appear in concentrations of up to 50% of the
chlorine dioxide demand where chlorine dioxide is
used for disinfection (8). Blood destruction, nephri-
tis, and methemoglobinemia have developed in
humans after acute poisoning with large doses of
chlorate (9,10). It was suggested that in chronic
poisoning from chlorate, uremia, anemia, and
nephritis might develop. Chlorite is thought to be a
more potent oxidant stressor to blood than chlorate
(11). Heffernan(12,13)reportedthatchloritebelonged
to a class of oxidant compounds that stimulate the
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reduced glutathione (GSH) levels and the develop-
ment of hemolytic anemia in animal models.
In attempting to establish minimal health effect
levels ofoxidants (chlorine dioxide and chlorite) on
erythrocytes, it is important to consider the effects
of such stressors on potential high risk groups. A
large group that falls into this category are persons
with lowered G6PD (glucose-6-phosphate dehydro-
genase)activity. G6PD-deficientcellshaveareduced
ability to produce NADPH via the pentose phos-
phate pathway (PPP), and consequently less GSH
is formed. Since GSH is the primary mechanism of
defense ofthe red blood cell against oxidant stress,
then persons with deficient G6PD levels have a
lowered capacity for protection against oxidants
(14, 15) and virtually 100 million males throughout
the world belong in this category (14). Among the
studiesreportedherearethosedesignedtoevaluate
the effects of chlorine dioxide and chlorite on
erythrocytes of mouse strains with differential
G6PD activity (i.e., the A/J strain has three times
the activity of the C57L/J strain).
Another potential high risk group would likely
include newborns. The potential effects of chlorite
on human newborns may be exaggerated because:
(1) infants consume nearly three times as much
liquid per unit of body weight than adults (16); (2)
infants are born with hemoglobin F (fetal hemoglo-
bin), a form that is readily oxidizable to methemo-
globin (17); (3) infants have a lower capacity than
adults to reduce methemoglobin enzymatically to32
hemoglobin (18); (4) newborn infants are character-
istically low in vitamin E (18), an important antiox-
idant compound, because there is little placental
transfer of vitamin E.
There is also evidence that the fetus may be at
increased risk to oxidant stressors. Shuval and
Gruener (19) demonstrated that nitrites can be
transferred to the fetus in utero causing an eleva-
tion ofMetHb in fetal blood. When administered in
drinking water to pregnant rats, 2000-3000 mg/l. of
NaNO2resulted in adecreased litter size, increased
mortality of pups in the first three weeks and a
lagging of growth rate despite having equal birth-
weight to controls.
Sodium chlorate has been shown to produce
methemoglobin in vitro and in vivo when adminis-
tered orally (9,10,20). Oral acute doses of sodium
chlorate have resulted in hemolysis, nephritis,
methemoglobinemia, and death in man and various
species of test animals (9). Since previous studies
have shown chlorate to cause renal damage, it was
hypothesized that chlorite, because of its more
potent oxidant capabilities, may also be potentially
harmful to the kidney.
In order to test the above hypotheses, a number
of experiments were performed on laboratory ani-
mals. The experiments were designed to measure
the effects of orally administered chlorite on blood
characteristics, kidney structure, as well as the
fertility, and the growth rate, mortality and devel-
opment of newborns.
Methods
Animal Care
Two strains ofmice, with "normal" (A/J) and low
(C57L/J) levels of G6PD activity, were obtained
from the Jackson Laboratory, Bar Harbor, Maine.
The mice were individually housed in stainless steel
cages equipped with constant feed'foodhoppers and
50 ml calibrated watering devices. The cages were
kept undercontrolled conditions of12cycles oflight
and dark (9 A.M. - 9 P.M. light, 9 P.M. - 9 A.M.
dark), and a temperature of 74±+2°F. Animals
were held at these conditions for a one-week period
after receipt in order to assess their health and
allow for acclimation. Animals were randomly allo-
cated to each ofthe treatment categories, according
to a random scheduling of treatments. Treatment
periods of 12 hr occurred during the dark cycle in
order to minimize decomposition of C102 by light
and to coincide with the nocturnal activity period of
the mice.
The watering devices were filled with the appro-
priate treatment solutions and a reading taken of
the volume both before and after the treatment
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period. The bottles were removed at the end ofthis
period, and no other water provided until the next
treatment period. Average daily consumption of
liquid was computed for each mouse, and an overall
average computed for each treatment category.
Mice were fed ad libitum a balanced rodent diet
(Purina Rodent Chow) composed of not less than
23% crude protein, 4.5% crude fat, 6.0% crude
fiber, 8.0% ash, and 2.5% minerals.
Experimental Procedures
Complete Blood Count (CBC). The Royco Cell-
crit IV Hematology System, consisting of Model
920-Acellcounter,Model720-Ahemoglobinometer
and Model 365-A diluter, was used to determine
redbloodcellcount(RBC), hematocrit (HCT), white
blood count (WBC) and hemoglobin concentration
(HBG). Mean corpuscular volume (MCV), mean
corpuscularhemoglobin(MCH)andmeancorpuscular
hemoglobin concentration (MCHC) were then com-
puted from these data.
Quality assurance ofequipment performance was
checked on a daily basis by means of commercial
standards, and equipment performance was mea-
sured by comparison ofautomated andmanualhema-
tocrits of the same blood sample.
ReticulocyteCount. Stainingofreticulocytes was
accomplished according to the procedure outlined
by Seiverd (21). A 1% physiological saline solution
of Brilliant Cresyl Blue was mixed with an equal
quantity of whole blood and allowed to stand for
20-30 min. The contents of the tube were then
remixed andasmearmade. Thesmearwasobserved
under oil immersion and atotal of500 cells counted.
The reticulocytes were expressed as a percentage
of the total number of cells counted.
Glucose-6-Phosphate Dehydrogenase Assay
(G6PD). G6PD activity was determined by a col-
orimetric procedure using Calibiochem (10933 N.
Torrey Pines Rd. LaJolla, Calif. 92037) G6PD
reagents and a Perkin-Elmer Coleman 55 spec-
trophotometer equipped with a flow-through tem-
perature-controlled cell, a Coleman 5-100 enzyme
calculator, and a Coleman 47 B.C.D. printer. The
G6PD activity was calculated in terms of Inter-
national Units (I.U.) per gram of hemoglobin in
whole blood hemolysate.
Osmotic Fragility (Automated). Osmotic fragil-
ity was determined using the American Optical
Fragilograph (Clinical Instruments Co., Dudley,
MA 01570). A 10 pul portion of whole blood was
diluted in 7.5 ml of 0.68% isotonic buffered saline
(Isoton II diluted to obtain 0.68%), yielding a 1:750
dilution. The instrument was calibrated with 1.5 ml
ofthe prepared cell suspension, added to a cuvette,
and the osmotic fragility determined.TOXICOLOGICAL EFFECTS OF CHLORITE
Glutathione (GSH) Assay. Reduced glutathione
was determined by using Glutathione and Erythro-
zyme Assay (from Princeton Biomedix Inc., Prince-
ton, NJ) using a reagent solution containing 5,5-
dithiobis(2-nitrobenzoic acid) (DTNB) which reacts
with glutathione to form a highly colored yellow
ion.
Statistical Analysis
Analysis was performed by using the BMDP2V
and SPSS ONEWAY (22) programs. The two-way
ANOVA table was produced by the BMDP pro-
gram with the three previously mentioned hypoth-
eses either accepted or rejected, based upon the p
values ofthe F test (p = 0.05). Ifa hypothesis was
rejected, contrasts were constructed and with sep-
arated variances computed with accompanying p
values. These contrasts were run on the SPSS
ONEWAYprogram(22). TheBartlettsandCochrans
tests for equal variances were also computed by
using the SPSS ONEWAY program.
Experimental Design
EffectofChlorite on ChlorineDioxide on Blood
Characteristics. Twenty A/J and 20 C57L/J mice
were each divided into two groups of 10 mice with
each strain being exposed to 0.0 ppm (10 mice) and
100 ppm (10 mice) chlorine dioxide in their drinking
water for 30 days. The animals were lightly ether-
ized and then decapitated by means of a guillotine.
The blood was collected into 100 ,ul of0.6% sodium
heparin (Sigma) prior to analysis.
BothA/J (N = 63)andC57L/J(N = 59)micewere
eachdividedintofourgroupsand exposed to sodium
chlorite at 0.0, 1.0, 10.0 and 100.0 ppm in their
drinking water for 30 days (Table 1). At the end of
the exposure period, blood was collected and ana-
lyzed as previously indicated. In addition to meas-
uringthe effects ofseveralblood parameters includ-
ing GSH levels, the weight change over30 days and
the average volume ofwaterconsumed perday was
determined for each animal.
Effect on Conception Rate and Litters ofAIJ
Strain Mice. Ten- to 12-week-old female A/J mice
were grouped by ten in an 11.5 in. long x 7.5 in.
wide x 5 in. deep polycarbonate breeding cage for
one weekin ordertosynchronize ovulation. Females
were then randomly mated one to one with A/J
males ofa similar age and checked forvaginalplugs
on the mornings ofthe next four days. Males were
removed from females at the appearance of plugs.
Date ofplugging, as well as weight ofsire and dam
were recorded. Females that were not plugged
were grouped for a week before breeding again.
Plugging was considered to be day one of preg-
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nancy and females were placed in fresh breeding
cages with wood chips for the duration of their
pregnancy and lactation. At plugging, females were
randomly assigned to either a control group which
was given distilled water or a treatment group
whichwasgiven 100ppmsodiumchlorite(Matheson,
Coleman and Bell, Norwood, OH 45212) in distilled
water. A dose of 100 ppm C1O2- was selected, since
other studies (12,13,23) have shown that effects on
hematological parameters are first observed at con-
centrations of chlorite reaching 50 to 100 ppm.
Females remained on the specified water during
gestation and lactation periods, and water intake
was monitored during this time.
At parturition each litter was examined and data
collected. Individual birth weights were taken and
pups were weighed once a week until weaning at 28
days. Statistical analysis was performed on the
data collected for each litter as well as water con-
sumption and rate of positive pregnancy for each
group.
Effects ofRenal Structure. Water used for all
treatment and control groups was processed by a
Continental Water Deionization System (Millipore
Corp., Bedford, Mass) and buffered with 1/30 M
Sorenson's phosphate buffer (24) to maintain a pH
of 7.17. Treatment water was prepared by the
addition ofappropriate amounts ofNaC1O2 (Matheson
Colemanand Bell, Norwood, Ohio)tobuffered "Con-
tinental" water. Water used for control groups
was prepared in a similar fashion with the addition
ofNaCl(SigmaChemicalCo., St. Louis, MO)instead
ofNaC1O2. Allwaterfortreatment and control mice
was available ad libitum, and the amount ofwater
consumed was recorded at every fresh change.
Measurement ofchloriteionconcentrationinfreshly
prepared treatment waterwas performed usingthe
DPD ferrous titrimetric method of Palin (25).
All mice were weighed and randomly allocated to
specifictime-exposure andtreatmentgroups. Lengths
of exposures of treatment and control mice were
divided into threetime-exposure periods: one group
of 55 mice for 30 exposure days, one group of 55
mice for 90 exposure days, and one group of60 mice
for 180 exposure days. The five treatment groups
within each time-exposure group were: 0.0 ppm
NaClO2 as anegative control, 4.0 ppm NaCIO2 (2.98
ppm as C102-), 20.0 ppm NaClO2 (14.92 ppm as
C102-), 100.0 ppmNaCIO2 (74.59 ppm asC1021, and
100.0 ppm sodium chloride (NaCl) as a high salt
control.
Upon completion of their respective treatment
periods, all animals were weighed and killed by
cervical dislocation. Both kidneys were excised,
weighed, dividedlongitudinallyintotwohemisections,
and placed in appropriate fixatives for subsequent
lightmicroscopyand/ortransmission electronmicros-34
copy. In preparation for light microscopy, portions
of renal tissue were fixed for 12 hr in Helly's
solution and subsequently chromated for 12 hr in a
3% potassiumdichromate solution(24). Kidneyhemi-
sections were embedded in paraffin, cut in 5 ,um
sections, and stained with hematoxylin and eosin-
phloxine B. Renal tissue from three randomized
mice in each group were processed for electron
microscopy. Portions ofrenal tissue were cut in 1.5
cm blocks and fixed overnight at 4°C in 2.6% glu-
taraldehyde in Millonig's phosphate buffer at pH
7.2 (26). The renal tissue was then finely diced and
post-fixed for 1 hr in Millonig-buffered 1% osmium
tetroxide solution. After Epon embedding and ultra-
thin sectioning, the tissues were stained with 7%
uranyl acetate and lead citrate (27). Electronmicros-
copy was performed by use of aJoel 100-S electron
microscope at 80 kV.
Results
Effect of Chlorine Dioxide and
Chlorite on Blood Characteristics
A total of 11 hematologic parameters were mea-
sured for effects ofchlorine dioxide exposure. Mice
exposed to sodium chlorite for 30 days exhibited
treatment effects for three of the eleven hemato-
logic parameters (Table 1). Specifically, there was an
increase in G6PD activity, MCV (mean corpuscular
volume) and osmotic fragility for both strains of
mice exposed to the 100.0 ppm chlorite, whereas no
significant differences from controls occurred for
the 1.0 and 10.0 ppm chlorite exposures.
It is also evident from analysis ofvariance (Table
1) that there is a significant difference between
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strains forboth G6PD activity (p < 0.001) and osmotic
fragility (p<0.001). There were no significant strain
versus treatment interactions, indicating that both
strains acted similarly to chlorite exposure with
respect to the parameters measured. These differ-
ences in hematological parameters from treatment
could not be explained by weight loss or gain (p =
0.146), or by differences in water consumption (p =
0.291) since there were no significant treatment
effects with respect to these parameters.
Effect of Chlorite on Conception Rate
and Litters of A/J Strain Mice
The means, standard deviations and t-results are
presented forcontrol and treatment groups in Table
2. The average number of pups born alive in each
litter was 5.4 for controls and 5.0 for the treatment
group (p = 0.33). The average number of pups alive
at weaning (4 weeks after birth) was greater at 4.2
pups for controls than for the 3.4 pups in the
treatment group (p = 0.24). In contrast to the
number ofliving pups, the average number of pups
per litter dead at birth was 1.5 for controls and 2.0
fortreatment animals (p = 0.25). The average num-
ber of pups per litter that died after birth but
before weaning was 1.3 for controls and 1.9 for the
treatment group (p = 0.214).
The control litters had an average live birth litter
weight of 1.27 g compared with 1.17 g for the
treatment group (p = 0.13). Two variables where
statistical significance wasreachedincludesthe aver-
aged weight of pups at weaning and the average
birth to weaning growth rate. The birth to weaning
growth rate was 0.336 g/day for treatment animals
while being significantly greater at 0.408 g/day for
Table 1. Analysis ofvariance and cell means for selected hematologic variables ofA/J and C57L/J mice exposed to 0.0, 10.0, and
100.0 ppm of sodium chlorite.
Cell means for Analysis of variance resultsa
Treatment, A/J C57L/J
Parameter ppm NaCl strain Na strain N S T ST
G6PD activity, IU/g of 0.0 6.10 16 1.88 14
hemoglobin in whole blood 1.0 6.05 12 1.74 11 0.000 0.000 0.902
10.0 5.90 12 1.82 11
100.0 6.50 23 2.13 23
Mean corpuscular volume 0.0 48.91 16 49.89 14
1.0 48.70 12 49.47 11 0.100 0.008 0.844
10.0 48.58 12 49.25 11
100.0 50.39 23 50.55 23
Osmotic fragility 0.0 0.440 12 0.458 11
1.0 0.440 12 0.453 11 0.000 0.084 0.875
10.0 0.438 12 0.458 11
100.0 0.452 12 0.465 11
aN = number ofmice tested per cell. Probability F exceeded for strain differences (S); treatment (T) differences; and strain versus
treatment (ST) interactions. When retested by orthogonal contrasting, significance was achieved (p = 0.05) for individual treatments.Table 2. Differences between control (0.00 ppm chlorite) and treatment (100 ppm chlorite) groups for ten variables.a
Control group Treatment group t-testb
Variable Mean S N Mean S N t df p
Liver litter size 5.4 2.5 21 5.0 3.3 12 0.42 31 0.339
No. alive at weaning 4.2 2.4 19 3.4 3.7 12 0.73 29 0.237
Avg. pup weaning weight 12.5 1.6 16 10.7 2.4 7 2.06 21 0.026
Birth-weaning growth rate 0.408 0.055 16 0.336 0.082 7 2.11 21 0.024
Gestation time 20.2 0.68 9 19.71 1.30 12 1.16b 17.1b 0.110
Breeding weight of mother 21.84 2.16 13 21.03 1.57 12 1.07 23 0.149
Age of mother at parturition (weeks) 18.0 3.9 21 18.5 4.21 12 - - -
Average liver birth litter weight 1.27 0.380 20 1.17 0.113 10 1.15b 24.7b 0.130
No. dead at birth 1.50 2.01 20 2.00 2.04 12 -0.68 30 0.252
No. survivors dying before weaning 1.32 1.77 19 1.90 2.02 10 -0.81 27 0.214
as = standard deviation; N = number oflitters. bt.separate statistic, with adjusted degrees offreedom, are presented, since the variances ofthe control and treatment groups are
shown to be unequal by the F-test (p = 0.10). Results are based on a one-sided test (HA: mean for controls litters > mean for
treatment litters).
Table 3. Analysis ofvariance for body weight (BW) change, kidney weight (KW), kidney: body weight ratio and weekly water
consumption.
Analysis of variancea
Parameter measured No. of mice L T L X T
Body weight change 167 0.000 0.690 0.808
Kidney weight 167 0.000 0.602 0.331
KW:BW ratio 167 0.103 0.348 0.602
H20 consumption 166 0.023 0.948 0.519
aProbability F exceeded for length ofexposure differences (L), treatment differences (7), and length ofexposure versus treatment
interactions (L x 7).
the control group (p = 0.024). Further, the average
weight at weaning was 10.7 g for the treatment
group and 12.5 g for the control group (p = 0.026).
The conception rate was also determined for con-
trol and treatment groups. All females positive for
vaginal plugs were randomly placed into control
and treatment groups. Not all plugged females
conceived or produced litters. The percentage of
dams that were plugged that also produced litters
was defined as the conception rate. The conception
rate for the treatment group was 39% and for
controls was 56%.
Since differences between groups in the weight
ofdams, age, gestation time, orthe amount ofwater
consumed might have influenced the development
of pups, these variables were measured. The gesta-
tion time of dams was not statistically different
between control and treatment groups (p = 0.110).
The average breeding weight ofthe treatment and
control dams was 21.03 and 21.84 g, respectively (p
= 0.149), while the age of mothers at parturition
was 18 weeks for controls and 18.5 weeks for the
treatment group. Finally, the level of water intake
between control and treatment groups was mea-
sured. The waterconsumed duringlactation isusually
greater than that consumed during gestation, so
these figures are presented separately. The control
dams consumed an average of 5.9 ml/day during
gestation and 15.6 ml/day during lactation. The
treatment group consumed 6.2 ml/day of chlorite-
treatedwaterduringgestation and 15.3ml/daydur-
ing lactation. The difference between treatment
and control groups in the amount of water con-
sumed was not significant for gestation period (p =
0.08) or lactation period (p = 0.87).
Effect of Chlorite Exposure on Kidney
Structure
Two-way analysis ofvariance revealed no statis-
tically significant treatment-related differences for
anyofthefourphysicalparameters measured (body
weight change, kidney weight, percent kidney to
body weight ratio and weekly water consumption).
Statistically significant length of exposure differ-
ences were observed inbodyweightchange, kidney
weight, and weekly water consumption; but a
significant difference was absent in the percent
kidney to body weight ratio (Table 3). Additionally,
no significant interaction occurred between length
oftreatment exposures and treatment levels ofany
of the four parameters.
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Chi-square analysis of mortality rates indicated
that these rates were not significantly different
between the 30-, 90- and 180-day groups nor be-
tween the five various treatment levels.
Macroscopically, the kidneys were normal. The
kidneys' outer surfaces were smooth, encapsulated,
and pinkish-brown in color. No external lesions or
growths were observed. Internally, the kidneys
were unilobar with a dark red medulla and a
pinkish-red cortex. No internal lesions, growths or
obstructions were observed.
Microscopic examination using light and trans-
mission electron microscopes revealed no evidence
ofglomerular, vascular, obstructive or tubular dis-
ease. Glomeruli, vasculature, and tubular networks
were freefrom significant nephritis, nephrosis, vas-
cular sclerosis, and obstructions. Ultrastructural or
minimal changes were not found.
Discussion
Based upon the data in this study and a previous
one (23), itappears that exposure ofA/J and C57L/J
mice to 100 ppm of chlorite for 30 days produces
increases in G6PD activity, mean corpuscular vol-
ume, osmotic fragility and acanthocytosis (regular
deformations or projections on the cell surface). In
vitro studies by Heffernan (11,12) revealed that
incubation of human and rat erythrocytes with
increasing concentrations of C102- produced a pro-
gression of alterations in the erythrocyte morphol-
ogy. Concentrationsof7.4 x 10 Mto7.4 x 103M
CIO2-producedmultiplesharppointeddeformations
on the membrane similar to effects seen in our in
vivo studies. In vivo studies by Abdel-Rahman et
al. (28) showedmorphologic changes in the erythro-
cytes ofrats and chickens drinking CO2, Cl02-, and
C103- daily for 3 months. These changes were in
the form of crenated spheres (echinocytes) with
distortions in the middle ofthe erythrocytes at 100
mg/l. ofC102-. Themorphologic changes to erythro-
cytesproduced byinvivo orinvitro C102-exposure
appear consistent among the results of different
experimenters with the in vivo threshold at 100
mg/l. of C102.
The studies of both Heffernan et al. (13) and
Abdel-Rahman et al. (28) demonstrated a decrease
in GSH levels of erythrocytes after in vivo expo-
sure of rats to chlorite. Neither the A/J or C57L
mice in our study revealed a similar decrease in
GSH. However, G6PD activities were elevated,
indicating that in the mice adaptation may have
been sufficient to prevent measurable decreases in
GSH. This did not preclude damage to cell mem-
branes which may be protected by other mecha-
nisms.
Heffernan et al. (13) reported that when rats
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were fed sodium chlorite, the levels of GSH were
the most markedly affected ofthe blood parameters
and declined in dose-response relation to chlorite
exposure, with levels of chlorite at 60 ppm causing
decreases of approximately 20% in GSH levels.
Additionally, decreasesinhemoglobin, redcellcount
and packed cell volume were also evident in the
study of Heffernan et al. (13), indicating a mild
hemolytic anemia. The present studies on mice (23)
exposed to 100 pm chlorite indicated an incrase in
MCV (mean corpuscular volume), osmotic fragility,
G6PD activity and the number of acanthocytes.
Recent in vitro studies by Moore et al. (29) have
revealed that human G6PD-deficient red cells are
more susceptible to chlorite-induced decreases in
GSH than are cells of humans with normal G6PD
activity. Future studies are needed to quantify to
what extent G6PD deficients may be at risk to
chlorite induced RBC alteration in normal exposure
conditions.
It should be emphasized that while the activity of
A/J strainwasthreetimesthatG6PD activity ofthe
C57L/J strain, a value comparable to the ratio of
normal to deficient human RBC G6PD activity, the
absolute comparisons are quite dissimilar. That is,
the C57L/J mice(i.e., theso-called "deficient"strain)
have RBC G6PD activity similar to that of normal
humans eventhoughthey showedonly 1/3theactiv-
ity level ofthe A/J strain. Thus, the C57L/J strain
did not represent a true deficient in absolute terms.
In fact, their ability to increase GSH levels follow-
ing chlorite stress suggests the ability to adapt to
oxidantstress. Likewise, unpublishedinvestigations
in our laboratory have shown that the C57L/J mice
were markedly resistant to primaquine, an oxidant
drug which is known to induce hemolytic anemia in
G6PD deficient humans (15). It thus seems that the
hypothesisthatG6PDdeficiencyenhancestheoccur-
renceofchlorite-induced hemolysisinhumansremains
tobe evaluated via amodel with adeficiencycompa-
rable in absolute terms to the human deficient
condition and/or epidemiologically.
Our studies of chlorite exposure on conception
rate and litters ofA/J mice have demonstrated that
there are no effects of ingested chlorite ion (100
ppm) on pregnant dams when measuring gestation
time, breeding weight or age at parturition. Conse-
quently, these variables do not appear to confound
the results. Additionally, there is no significant
difference in litter size, which also rules this out as
a confounding factor in influencing weaning weight
and birth-weaning growth rate. Although the num-
ber ofpups alive at weaning was somewhat greater
for the controls, this difference again was not
significant. It would be expected that fewer mice in
a litter either at birth or prior to the weaning
process would result in greater weight gains. How-TOXICOLOGICAL EFFECTS OF CHLORITE 37
ever, there were fewer in the treatment groups
alive at weaning, yet they weighed significantly
less on the average than controls, and had less
weight gain. These results appear similar to those
of Shuval and Gruener (19) who reported that pups
ofdamswhiledrinkingwaterwithnitrite (1000-3000
mg/l.) experienced increased mortality in the first
three weeks and lagged behind in growth, despite
having equal birth weights to controls. The concep-
tionrate ofthedamsdrinkingchlorite-treated water
wasreduced 17% compared tocontrols. Thesefindings
indicate that chlorite ion at 100 ppm concentration
is capable of reducing the conception rate of A/J
mice and of retarding the growth rate of A/J pups
through weaning. Levels of 100 ppm chlorite repre-
sent a 10- to 100-fold increase over expected con-
centrations in drinking water and additional studies
are being undertaken to determine minimal health
effect levels. The series of sodium chlorite doses
administered orally in drinking water did not result
in any detectable toxic damage to the kidneys of
C57L/J male mice over the 60-, 90- or 180-day
exposure periods.
Environmental Protection Agency Health Effects Research Group
inCincinnati, OH, grantnumberR-805-993-020. Segmentsofthis
research have appeared previously (29,30).
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